Teo Soleymani is a Dermatology physician affiliated with City Of Hope National Medical Center. OpenAlex indexes 44 publications with 1,348 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
50 Bellefontaine St Ste 202
Pasadena, CA 911053132
Telephone
626-654-3376Provider last certified this registry record 25 Oct 2024.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year202511 payments$16,235openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202513 payments
- Organogenesis Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
36.8%Tetracycline-class Drug18.6%Doxycycline Hyclate100%Part D≥110 patientsAzole Antifungal14%Ketoconazole100%Part D≥28 patients+ 1 more class in this area
Dermatology
23%Corticosteroid23%Triamcinolone Acetonide52%Triamcinolone acetonide40%Fluocinolone Acetonide9%Part D + Part B<11 patientsSensory organs
16.2%Corticosteroid14.6%Clobetasol Propionate59%Desonide41%Part D≥30 patientsAminoglycoside Antibacterial1.7%Gentamicin Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Atypical fibroxanthoma, pleomorphic dermal sarcoma, and undifferentiated sarcoma: Updates on diagnosis, management, and surveillance
Journal of the American Academy of Dermatology
2026 - 64627 Novel Oral Supplementation for Skin Cancer Prevention and Sun Protection
Journal of the American Academy of Dermatology
2025 - Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study
Journal of the National Comprehensive Cancer Network
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Yuman Fong, MD
City Of Hope National Medical Center
Ravi Salgia, MD, PhD
City Of Hope National Medical Center
Stephen Gruber, MD
City Of Hope National Medical Center
Tanya Siddiqi, MD
City Of Hope National Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”